Deciphering Complex Lab Data With Machine Learning

07/26/2021 By Andrea

Authored and contributed to PharmaLeaders by Jason Bhan, MD Accurate analysis of healthcare data is critical for research, delivery of care, treatment variability, and improving patient outcomes. The ability to identify patterns in real-world data (RWD) demands insights with faster speeds, greater specificity, and improved accuracy. And the challenges are increasing as more healthcare data […]

The Roadmap to Real-Time Data Sharing in Clinical Trials

07/14/2021 By Andrea

Article authored and contributed to PharmaLeaders by Marc Leighton, VP of Product for Florence Healthcare With the rise of decentralized technology across the clinical trial industry, real-time data sharing has become critical. If research sites, local physicians, trial participants, CROs, and sponsors can’t instantly share data with one another, remote or hybrid clinical trials will […]

US FDA’s VRBPAC recommends J&J Covid-19 vaccine booster shot

10/23/2021

The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has unanimously recommended grant of Emergency Use Authorization (EUA) for Johnson & Johnson’s The post US FDA’s VRBPAC recommends J&J Covid-19 vaccine booster shot appeared … [Read More...]

EMA approves two new sites for making Pfizer-BioNTech’s Covid-19 vaccine

10/23/2021

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved two additional production sites for making Pfizer-BioNTech’s Covid-19 vaccine, Comirnaty. Both the facilities The post EMA approves two new sites for making Pfizer-BioNTech’s Covid-19 vaccine … [Read More...]

Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics

10/22/2021

Silence Therapeutics has announced collaboration with Hansoh Pharmaceutical to develop new therapeutics using Silence’s mRNAi GOLD platform. As part of the collaboration, the companies will develop novel short The post Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics … [Read More...]

Atreca, Gates MRI partner to develop antibody for malaria prevention

10/22/2021

Clinical-stage biotechnology firm Atreca has signed a licensing agreement with the Bill & Melinda Gates Medical Research Institute (Gates MRI) for the development of a monoclonal antibody to The post Atreca, Gates MRI partner to develop antibody for malaria prevention appeared first on … [Read More...]

Featured Article

Deciphering Complex Lab Data With Machine Learning

The Roadmap to Real-Time Data Sharing in Clinical Trials

White Papers

Virtual Programs for the Life Sciences & Healthcare

Healthcare Marketing Trends for 2019 Emphasize Better Targeting with Cost-Effective Advantages

Industry News

US FDA’s VRBPAC recommends J&J Covid-19 vaccine booster shot

EMA approves two new sites for making Pfizer-BioNTech’s Covid-19 vaccine

Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics

Atreca, Gates MRI partner to develop antibody for malaria prevention